Libra Therapeutics

Libra Therapeutics

Biotechnology Research San Diego, California, United States 6 employees
Employees
6
Contacts
1
Emails
1

Libra Therapeutics Overview

Headquarters
San Diego, California, United States
Industry
Biotechnology Research
Employees
6
Founded
2019
Funding
29.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Libra Therapeutics

Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases. These include amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's, Parkinson's, and Huntington's disease, which are all characterized by cellular disequilibrium caused by the production and decreased clearance of neurotoxic proteins. The company’s therapeutic platform is uniquely positioned to discover and develop small molecule drugs with distinct molecular approaches that can 1) increase autophagy to more rapidly clear toxic proteins and 2) attenuate the production of neurotoxic proteins.

Libra Therapeutics Contact Details

People in AeroLeads
3
With contact data
1
Email contacts
1
33.3% coverage

Libra Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Shawn Scranton. Pharmd President and Chief Executive Officer
Email
Isaac Veinbergs Cbo at Libra Therapeutics
View
Stefan Lohmer Co-founder & Chairman of the Board
View

Employees by Management Level

Executive 2 profiles
Individual contributor 1 profile

Compare Similar Companies to Libra Therapeutics